Presentation: Defending High-Value Portfolios to Minimize Litigation Risk & Protect Market Access
Time: 2:45 pm
day: Day Two
Details:
- Analyze litigation trends in CRISPR, LNP, and gene editing patent battles
- Understand how enablement rulings and biosimilar threats impact advanced therapy IP
- Explore portfolio tactics that strengthen positioning in disputes and due diligence
